I listened to a Morgan Stanley NEA update today (not shareable unfortunately).
Key points -
NEA 2H sales in US was the highlight of the performance by beating the top-end of their prior range by~3% with all of the ACV of that delivered in May & June which is significant on a run-rate basis.
Upgrades in the top line trajectory for ACV, with reinvestments on their cost base which means bigger loses in CY22 & CY23, but underpinned by a stronger business case with better returns on investment.
Legal case - NEA has more than tripled it's US business in last 3yrs, which has changed the US market dynamics for Eagleview who have had a market leading position in what is a high margin business.
Eagleview is private equity backed & heavily geared i.e. leveraged both financially & operationally.
GLTA SH
- Forums
- ASX - By Stock
- NEA
- Ann: FY21 preliminary results, exceeds recently upgraded guidance
Ann: FY21 preliminary results, exceeds recently upgraded guidance, page-79
-
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online